Sun Nelson
- SEC CIK
- 0002045377
In the past year, 1 open-market purchase filing worth $43.2K and 1 sale filing worth $395.0K.
Current role at each company
- AARD Aardvark Therapeutics, Inc.See Remarksas of Sep 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $43.2K
- 1 filing
- Sold
- $395.0K
- 1 filing
- Net
- −$351.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sun Nelson as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 (view filing) | Feb 14 | 5 days | Sun NelsonChief Financial Officer | PPurchase | +10.0K | $16.00 | +$160.0K | +11.2%99.5K after | |
| Sep 10, 2025 (view filing) | Sep 9 | 1 day | Sun NelsonChief Financial Officer | PPurchase | +6.00K | $8.07 | +$48.4K | +6.0%105.5K after | |
| Dec 12, 2025 (view filing) | Dec 11 | 1 day | Sun NelsonChief Financial Officer | PPurchase | +3.00K | $14.40 | +$43.2K | +2.8%108.5K after | |
| Sep 11, 2026 (view filing)8:14 PM ET | Sep 10-11 | 1 day | Sun NelsonSee Remarks | SSaleCommon Stock, par value $0.00001 per share | −76.8K | $5.15 | −$395.0K | −68.4%35.5K after | 2 lots10b5-1 |